Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer

NCT02549677 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

294

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Epirubicin
DRUG: Docetaxel
DRUG: cyclophosphamide

Sponsor

Ruijin Hospital